R1, an industry leader in revenue cycle management (“RCM”) with over 20 years of experience, and Palantir Technologies (NASDAQ:PLTR), a leader in arti ...
Administrative costs currently make up more than 40% of U.S. hospital expenses, with over $160 billion spent on Revenue Cycle ...
The developer is subleasing space from Vital Proteins after striking a deal to lease its current home to a growing tenant in ...
R1 RCM and Palantir Technologies are partnering to launch R37, an advanced artificial intelligence lab dedicated to "revolutionizing healthcare financial performance." ...
Under the terms of the agreement, TowerBrook, which has a 36% stake in R1 RCM, and CD&R will acquire all the outstanding ...
R1's accolades include awards in Ambulatory RCM Services (EHR-Agnostic), Extended Business Office: Small (200 beds), and Government Reimbursement Services. This achievement marks the fifth consecutive ...
Over the last year, R1 Rcm share price has been traded in a range of 3.73, hitting a high of 14.31, and a low of 10.58. R1 Rcm is listed on the CBOE trading with ticker code RCM.US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback